AI Model Using EHR Data Predicts 5-Year Survival in Colorectal Cancer
Pharmacy-Based FIT Screening Could Boost Colorectal Cancer Detection
Berberine Shows Lasting Protection Against Colorectal Adenoma Recurrence
Oxaliplatin Boosts Survival in Stage III CRC Only Up to 70 Years, Study Finds
Exploring Amivantamab's Potential in Colorectal Cancer: Dirk Arnold, MD, PhD
The Importance of Early Screening, Biomarker Testing, and Support in Colorectal Cancer Care
Tackling Colorectal Cancer Care Inequities Through Patient Advocacy Groups
Patients With Colorectal Cancer Seek More Say in Treatment, Face Financial Barriers
A Look at Cancers Where Biomarkers Are Needed
Dr Ajay Goel Explains Effectiveness of Liquid Biopsies, Tissue-Based Biomarkers in Treating CRC
Dr Ajay Goel Discusses New Methods of Testing for EOCRC, Recurrence
Botensilimab and Balstilimab in Refractory Microsatellite Stable (MSS) mCRC
Impact of Microsatellite Stability in Metastatic Colorectal Cancer
Utilizing RWE to Address Unmet Needs for CRC